:CYPAFB1HCC

Asmaa Ashraf Mohamed1, Monica Armanious1, Rana W Bedair1

  • 1Clinical Pharmacology and Pharmacogenomics Research Group, Department of Pharmacology and Toxicology, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, Egypt.

概括

在CYP酶的遗传变异影响易感性阿弗拉托克素B1诱导的肝癌. 了解这些单核酸多态 (SNP) 是个性化肝细胞癌 (HCC) 风险评估和治疗策略的关键.